Key Dates

Related Announcements

• May 10, 2024 - ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/UH3 Clinical Trials Not Allowed). See NOFO RFA-HG-24-004.

Issued by

National Institute on Aging (NIA)

Purpose

This Notice informs that, effective immediately, the National Institute on Aging (NIA) is participating in RFA-HG-24-004, “ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/UH3 Clinical Trials Not Allowed).”

To document NIA’s participation, the following sections of RFA-HG-24-004 were modified:

Part 1. Overview Information

Components of Participating Organizations

Currently Reads:

National Human Genome Research Institute (NHGRI)

All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.

Office of Data Science Strategy (ODSS)

Modified to Read (changes shown in bold italics):

National Human Genome Research Institute (NHGRI)

National Institute on Aging (NIA)

All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.

Office of Data Science Strategy (ODSS)
 

Assistance Listing Number(s)

Currently Reads:

93.172, 93.310

Modified to Read (changes shown in bold italics):

93.172, 93.310, 93.866
 

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

This section was modified to add:

National Institute on Aging (NIA)

NIA leads the federal government in conducting and supporting research on aging and the health and well-being of older people and is the lead within NIH for research on Alzheimer’s disease and related forms of dementia (AD/ADRD). To fulfill its mission, NIA supports technologies which aim to increase the research community's understanding of the aging process, as well as diseases, conditions, and needs associated with growing older, in order to extend the healthy, active years of life.  NIA invites proposed MAGen Site applications that align with NIA's mission and that focus on pathogenic variants that are associated with diseases and conditions associated with growing older, including those associated with AD/ADRD.

Section VII. Agency Contacts

This section was modified to add:

Scientific/Research Contact(s)

Jennie Larkin, Ph.D.
Division of Neuroscience (DN)  
National Institute on Aging (NIA)
E-mail: [email protected]

Financial/Grants Management Contact(s)

Jeni Smits
National Institute on Aging (NIA)
E-mail: [email protected]

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries to:

Jennie Larkin, Ph.D.
Division of Neuroscience (DN)  
National Institute on Aging (NIA)
E-mail: [email protected]